Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background Intragastric balloon (IGB) placement and endoscopic sleeve gastroplasty (ESG) are reported to be safe and effective endoscopic bariatric therapies. This study aimed to compare the patient demographics and therapeutic outcomes between the IGB and ESG procedures. Methods: This was a retrospective review of prospectively collected data from consecutive patients between December 2015 and October 2017 who underwent IGB or ESG at a single academic center. Fluid-filled IGBs implanted for a 6-month duration were used. IGB and ESG patients were subjected to identical post-procedure dietary instructions and follow-up protocols. Body weight was recorded at 1, 3, 6, and 12 months post-procedure. Results A total of 47 patients underwent IGB insertion and 58 underwent ESG. The IGB cohort had a lower baseline body mass index (BMI) than the ESG (34.5 vs. 41.5 kg/m2; P < 0.001) and a significantly lower proportion of men (2.1 % vs. 41.4 %; P < 0.001). IGB patients showed a mean (standard deviation [SD]) percentage total body weight loss (%TBWL) that was significantly lower than ESG patients at 1 month (6.6 % [2.6 %] vs. 9.9 % [2.4 %]; P < 0.001), 3 months (11.1 % [4.4 %] vs. 14.3 % [4.6 %]; P = 0.004), 6 months (15.0 % [7.6 %] vs. 19.5 % [5.7 %]; P = 0.01), and 12 months (13.9 % [9.0 %] vs. 21.3 % [6.6 %]; P = 0.005). The IGB cohort also experienced significantly more adverse events compared with the ESG (17 % vs. 5.2 %; P = 0.048). Conclusions IGB placement and ESG result in clinically meaningful weight loss. However, ESG appears to provide clinically superior and more enduring weight loss with fewer adverse events compared with an IGB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Sacks, F. M., Bray, G. A., Carey, V. J., Smith, S. R., Ryan, D. H., Anton, S. D., McManus, K., Champagne, C. M., Bishop, L. M., Laranjo, N., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804748 · Cited by 1,966 · cited 1×
“Research on dietary interventions that support long-term weight loss emphasizes the importance of regular attendance at a weight management program, which has been significantly associated with weight loss [24].”
Ponce, J., Woodman, G., Swain, J., Wilson, E., English, W., Ikramuddin, S., Bour, E., Edmundowicz, S., Snyder, B., Soto, F., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.006 · Cited by 279
Sharaiha, R. Z., Kumta, N. A., Saumoy, M., Desai, A. P., Sarkisian, A. M., Benevenuto, A., Tyberg, A., Kumar, R., Igel, L., Verna, E. C., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.12.012 · Cited by 268 · cited 2×
“ESG, comparatively, has not been associated with weight recidivism in our study or prior studies [15,21 – 23].”
Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.
Courcoulas, A., Abu Dayyeh, B. K., Eaton, L., Robinson, J., Woodman, G., Fusco, M., Shayani, V, Billy, H., Pambianco, D., & Gostout, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2016.229 · Cited by 167 · cited 4×
“The primary limitation of IGB therapy is the common occurrence of weight regain [7,8], even in a clinical trial setting [9,10], which is thought to be due to the necessary removal of the balloon at 6 months.”
InfluentialEndoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success
Lopez-Nava, G., Galvao, M., Bautista-Castaño, I., Fernandez-Corbelle, J., & Trell, M. (2016) · Endoscopy International Open · doi:10.1055/s-0041-110771 · Cited by 122
Popov, V. B., Ou, A., Schulman, A. R., & Thompson, C. C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.530 · Cited by 100
Cited by
Endoscopic intragastric balloon: a gimmick or a viable option for obesity?
Claudia Gollisch, K. S., & Raddatz, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.67 · Cited by 37
“Finally, Endoscopic sleeve gastroplasty, as a minimally invasive procedure to reduce gastric volume, also seems to be more effective than IGB therapy (68).”
BackgroundUpdates in endoscopic bariatric and metabolic therapies.
Qureshi, H., Saeed, N., & Jovani, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031126 · Cited by 21
Lee, S.-Y., Lai, H., Chua, Y. J., Wang, M. X., & Lee, G.-H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.880749 · Cited by 14
Metadata
- Authors
- Fayad, L., Cheskin, L. J., Adam, A., Badurdeen, D. S., Hill, C., Agnihotri, A., Dunlap, M., Simsek, C., Khashab, M. A., Kalloo, A. N., & Kumbhari, V.
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2019-03-06
- Volume
- 51
- Issue
- 06
- Pages
- 532-539
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W2921797313
- Cited by
- 66
- References
- 6
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. https://app.cochat.ai/papers/10.1055/a-0852-3441
- The paper
- Fayad, L., Cheskin, L. J., Adam, A., Badurdeen, D. S., Hill, C., Agnihotri, A., Dunlap, M., Simsek, C., Khashab, M. A., Kalloo, A. N., & Kumbhari, V. (2019). Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy. https://doi.org/10.1055/a-0852-3441
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.